Duopharma Biotech Bhd (7148) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Duopharma Biotech Bhd (7148) has a cash flow conversion efficiency ratio of 0.033x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM25.12 Million ≈ $6.31 Million USD) by net assets (RM757.35 Million ≈ $190.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Duopharma Biotech Bhd (7148) flexibility index to assess the company's free cash flow relative to its total liabilities.
Duopharma Biotech Bhd - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Duopharma Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Duopharma Biotech Bhd (7148) total market value for the company's overall valuation and market capitalisation.
Duopharma Biotech Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Duopharma Biotech Bhd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Newron Pharmaceuticals SpA
SW:NWRN
|
0.119x |
|
Shiyan Taixiang Industry Co. Ltd. A
SHE:301192
|
0.026x |
|
Parag Milk Foods Limited
NSE:PARAGMILK
|
0.079x |
|
Wuhan Citms Technology Co Ltd
SHG:688038
|
-0.054x |
|
Ser Educacional Sa
SA:SEER3
|
0.073x |
|
Daelim Paper Co.Ltd
KQ:017650
|
0.018x |
|
Sonda S.A
SN:SONDA
|
0.054x |
|
Zhejiang Benli Technology Co. Ltd.
SHE:301065
|
N/A |
Annual Cash Flow Conversion Efficiency for Duopharma Biotech Bhd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Duopharma Biotech Bhd from 2006 to 2025. View latest Duopharma Biotech Bhd stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | RM757.62 Million ≈ $190.21 Million |
RM112.71 Million ≈ $28.30 Million |
0.149x | +28.40% |
| 2024-12-31 | RM709.15 Million ≈ $178.04 Million |
RM82.16 Million ≈ $20.63 Million |
0.116x | +54.42% |
| 2023-12-31 | RM687.12 Million ≈ $172.51 Million |
RM51.55 Million ≈ $12.94 Million |
0.075x | -30.04% |
| 2022-12-31 | RM655.22 Million ≈ $164.50 Million |
RM70.27 Million ≈ $17.64 Million |
0.107x | +54.89% |
| 2021-12-31 | RM624.00 Million ≈ $156.67 Million |
RM43.20 Million ≈ $10.85 Million |
0.069x | -37.52% |
| 2020-12-31 | RM643.82 Million ≈ $161.64 Million |
RM71.35 Million ≈ $17.91 Million |
0.111x | -12.32% |
| 2019-12-31 | RM529.75 Million ≈ $133.00 Million |
RM66.96 Million ≈ $16.81 Million |
0.126x | -15.94% |
| 2018-12-31 | RM481.04 Million ≈ $120.77 Million |
RM72.33 Million ≈ $18.16 Million |
0.150x | +28.73% |
| 2017-12-31 | RM479.87 Million ≈ $120.48 Million |
RM56.05 Million ≈ $14.07 Million |
0.117x | +59.71% |
| 2016-12-31 | RM454.52 Million ≈ $114.11 Million |
RM33.24 Million ≈ $8.35 Million |
0.073x | +164.65% |
| 2015-12-31 | RM449.72 Million ≈ $112.91 Million |
RM-50.88 Million ≈ $-12.77 Million |
-0.113x | -160.89% |
| 2014-12-31 | RM193.63 Million ≈ $48.61 Million |
RM35.97 Million ≈ $9.03 Million |
0.186x | -14.16% |
| 2013-12-31 | RM182.65 Million ≈ $45.86 Million |
RM39.53 Million ≈ $9.93 Million |
0.216x | -4.12% |
| 2012-12-31 | RM170.50 Million ≈ $42.81 Million |
RM38.49 Million ≈ $9.66 Million |
0.226x | +91.65% |
| 2011-12-31 | RM164.44 Million ≈ $41.29 Million |
RM19.37 Million ≈ $4.86 Million |
0.118x | -53.56% |
| 2010-12-31 | RM157.87 Million ≈ $39.64 Million |
RM40.04 Million ≈ $10.05 Million |
0.254x | +33.09% |
| 2009-12-31 | RM142.74 Million ≈ $35.84 Million |
RM27.20 Million ≈ $6.83 Million |
0.191x | -5.97% |
| 2008-12-31 | RM130.55 Million ≈ $32.78 Million |
RM26.46 Million ≈ $6.64 Million |
0.203x | -7.77% |
| 2007-12-31 | RM114.21 Million ≈ $28.68 Million |
RM25.10 Million ≈ $6.30 Million |
0.220x | +18.17% |
| 2006-12-31 | RM145.43 Million ≈ $36.51 Million |
RM27.04 Million ≈ $6.79 Million |
0.186x | -- |
About Duopharma Biotech Bhd
Duopharma Biotech Berhad, together with its subsidiaries, researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally. It offers consumer healthcare products, including vitamins, minerals, and supplements under the Flavettes, PROVITON, PROVITON STR, CHAMPS, and Naturalle brand names; analgesics and antitussives… Read more